Carboplatin and etoposide chemotherapy in extrapulmonary poorly differentiated neuroendocrine carcinomas

被引：0
|
作者：
Galdy, S. [1 ]
Aurilio, G. [1 ]
Radice, D. [1 ]
Spada, F. [1 ]
Cella, C. A. [1 ]
Frezza, A. M. [1 ]
Nole, F. [1 ]
Fazio, N. [1 ]
机构：
[1] Ist Europeo Oncol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
R20
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [31] Cisplatin and Etoposide as First-line Chemotherapy for Poorly Differentiated Neuroendocrine Carcinoma of the Hepatobiliary Tract and Pancreas
    Iwasa, Satoru
    Morizane, Chigusa
    Okusaka, Takuji
    Ueno, Hideki
    Ikeda, Masafumi
    Kondo, Shunsuke
    Tanaka, Tsutomu
    Nakachi, Kohei
    Mitsunaga, Shuichi
    Kojima, Yasushi
    Hagihara, Atsushi
    Hiraoka, Nobuyoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (04) : 313 - 318
  • [32] Irinotecan-Based Regimens for the Second-Line Treatment of Extrapulmonary Poorly Differentiated Neuroendocrine Carcinomas: A Monocentric Experience
    Bardasi, C.
    Caputo, F.
    Santini, C.
    Cerma, K.
    Gardini, Casadei A.
    Andrikou, K.
    Salati, M.
    Fontana, A.
    Spallanzani, A.
    Bertolini, F.
    Luppi, G.
    Gelsomino, F.
    NEUROENDOCRINOLOGY, 2020, 110 : 180 - 180
  • [33] Comparative Study of Lung and Extrapulmonary Poorly Differentiated Neuroendocrine Carcinomas: A SEER Database Analysis of 162,983 Cases
    Dasari, Arvind
    Mehta, Kathan
    Byers, Lauren A.
    Sorbye, Halfdan
    Yao, James C.
    CANCER, 2018, 124 (04) : 807 - 815
  • [34] Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part B (pembrolizumab plus chemotherapy).
    Chan, Jennifer A.
    Raj, Nitya Prabhakar
    Aggarwal, Rahul Raj
    Calabrese, Susan
    DeMore, April
    Dhawan, Mallika Sachdev
    Fattah, Delaire
    Fong, Lawrence
    Grabowsky, Jennifer
    Hope, Thomas A.
    Kolli, Kanti Pallav
    Munster, Pamela N.
    Perez, Kimberly
    Reidy, Diane Lauren
    Von Fedak, Sofia
    Zhang, Li
    Bergsland, Emily K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
    Munhoz, Rodrigo Ramella
    de Mendonca Rego, Juliana Florinda
    de Celis Ferrari, Anezka Rubim
    Braghiroli, Maria Ignez
    Bariani, Giovanni Mendonca
    Hoff, Paulo Marcelo
    Costa, Frederico Perego
    Flesch Pfiffer, Tulio Eduardo
    Riechelmann, Rachel
    RARE TUMORS, 2013, 5 (03) : 135 - 139
  • [36] Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma
    Ikeda, Masafumi
    Okuyama, Hiroyuki
    Takahashi, Hideaki
    Ohno, Izumi
    Shimizu, Satoshi
    Mitsunaga, Shuichi
    Kondo, Shunsuke
    Morizane, Chigusa
    Ueno, Hideki
    Okusaka, Takuji
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2015, 22 (08) : 623 - 627
  • [37] Effectiveness of Adjuvant Chemotherapy for Patients with Poorly Differentiated Colorectal Neuroendocrine Carcinomas: A Study of the National Cancer Database
    Mao, R.
    Li, K.
    Luo, S.
    Turner, M.
    Cai, J. Q.
    Blazer, D., III
    Zhao, H.
    NEUROENDOCRINOLOGY, 2019, 108 : 152 - 152
  • [38] Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas
    Mao, Rui
    Li, Kan
    Cai, Jian-Qiang
    Luo, Sheng
    Turner, Megan
    Blazer, Dan, III
    Zhao, Hong
    ANNALS OF SURGERY, 2021, 274 (02) : E126 - E133
  • [39] Phase 2 Trial of Pembrolizumab-Based Therapy in Previously Treated Extrapulmonary Poorly-Differentiated Neuroendocrine Carcinomas: Results of Part B (Pembrolizumab Plus Chemotherapy)
    Chan, Jennifer A.
    Raj, Nitya P.
    Aggarwal, Rahul R.
    Hope, Thomas A.
    Kolli, K. Pallav
    Zhang, Li
    Fattah, Delaire
    Calabrese, Susan
    Grabowsky, Jennifer A.
    Perez, Kimberly
    Von Fedak, Sofia
    DeMore, April
    Munster, Pamela N.
    Dhawan, Mallika
    Reidy-Lagunes, Diane
    Fong, Lawrence
    Bergsland, Emily K.
    PANCREAS, 2022, 51 (03) : E40 - E41
  • [40] Cisplatin-Based versus Carboplatin-Based Chemotherapy for Extrapulmonary Neuroendocrine Carcinomas: A Real-World Study
    Abdel-Rahman, Omar
    Koski, Sheryl L.
    NEUROENDOCRINOLOGY, 2022, 112 (08) : 777 - 783
12345